Vedolizumab Therapy With or Without an Immunosuppressant for the Therapy of Inflammatory Bowel Disease: A Single Center Experience

被引：0
|
作者：
Chilukuri, Prianka
Xu, Huiping
Bohm, Matthew
Sagi, Sashivar
Fischer, Monika
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32748-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1906
引用
收藏
页码：S812 / S813
页数：2
相关论文
共 50 条
  • [1] Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
    Erdogan, Cagdas
    Yesil, Bayram
    Bacaksiz, Ferhat
    Ari, Derya
    Gokbulut, Volkan
    Yuksel, Mahmut
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 831 - 837
  • [2] Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
    Conrad, Maire A.
    Stein, Ronen E.
    Maxwell, Elizabeth C.
    Albenberg, Lindsey
    Baldassano, Robert N.
    Dawany, Noor
    Grossman, Andrew B.
    Mamula, Petar
    Piccoli, David A.
    Kelsen, Judith R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (10) : 2425 - 2431
  • [3] TACROLIMUS AS BRIDGE THERAPY FOR VEDOLIZUMAB AND USTEKINUMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: EXPERIENCE AND OUTCOMES IN A TERTIARY CENTER IN SOUTH FLORIDA
    Gonzalez, Maria S. Lopez
    Zaidi, Zara
    Perez, Carla
    Crim, Alisa J. Muniz
    Oquendo, Luis F. Caicedo
    Felipez, Lina Maria
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S494 - S494
  • [4] SINGLE CENTER EXPERIENCE OF LONG TERM VEDOLIZUMAB EFFICACY IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Singh, Namita
    Dubinsky, Marla
    Singh, Avantika
    Check, Morgan
    Rabizadeh, Shervin
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S959 - S960
  • [5] Single-Center Experience of Vedolizumab in Patients With Inflammatory Bowel Disease: Does Age Matter?
    Morganstern, Bradley
    Singh, Namita
    Targan, Stephan
    Landers, Carol J.
    Nguyen, Minh
    Vasiliauskas, Eric A.
    Shih, David
    Feldman, Edward J.
    Ippoliti, Andrew
    McGovern, Dermot
    Dubinsky, Marla
    Rabizadeh, Shervin
    Melmed, Gil Y.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S250 - S250
  • [6] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    [J]. Digestive Diseases and Sciences, 2018, 63 : 825 - 833
  • [7] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [8] Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease
    Steenholdt, Casper
    Lorentsen, Ruben Due
    Petersen, Pernille Norgaard
    Widigson, Ella S. K.
    Kloft, Charlotte
    Klaasen, Rolf Anton
    Brynskov, Jorn
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (06) : 1088 - 1098
  • [9] VEDOLIZUMAB THERAPY FOR VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE
    Shaul, Eliana
    Conrad, Maire A.
    Dawany, Noor
    Patel, Trusha
    Canavan, Megan C.
    Kelsen, Judith R.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1112 - S1112
  • [10] Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
    Singh, Namita
    Rabizadeh, Shervin
    Jossen, Jacqueline
    Pittman, Nanci
    Check, Morgan
    Hashemi, Ghonche
    Phan, Becky L.
    Hyams, Jeffrey S.
    Dubinsky, Marla C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2121 - 2126
12345